NCT03924011View on ClinicalTrials.gov

Photobiomodulation Therapy for the Prevention of Acute Radiodermatitis in Breast Cancer Patients Undergoing Radiotherapy

NACompletedINTERVENTIONAL
Enrollment

71

Participants

Timeline

Start Date

July 1, 2020

Primary Completion Date

March 1, 2021

Study Completion Date

June 1, 2021

Conditions
RadiodermatitisBreast Cancer
Interventions
DEVICE

Photobiomodulation therapy (PBMT)

PBMT sessions will be planned 2x/week after RT.

DEVICE

Sham laser

Sham laser sessions will be applied 2x/week after RT.

Trial Locations (2)

3500

Jessa Ziekenhuis, Hasselt

3600

Ziekenhuis Oost-Limburg Campus St.-Jan, Genk

All Listed Sponsors
collaborator

Jessa Hospital

OTHER

collaborator

Ziekenhuis Oost-Limburg

OTHER

lead

Hasselt University

OTHER

NCT03924011 - Photobiomodulation Therapy for the Prevention of Acute Radiodermatitis in Breast Cancer Patients Undergoing Radiotherapy | Biotech Hunter | Biotech Hunter